HealthQuill FDA
Pfizer Inc’s Abrysvo, a vaccine used in pregnant women to prevent lower respiratory tract infection caused by respiratory syncytial virus (RSV) in infants, was approved by the FDA.
Drugs Health Pharma

Pfizer gets FDA nod for infant respiratory tract infection vaccine

HQ Team August 22, 2023: Pfizer Inc’s Abrysvo, a vaccine used in pregnant women to prevent lower respiratory tract infection caused by respiratory.

Read More
Research uncovers significant discrepancies in ingredient labels and presence of banned compounds
Drugs Health Medical

Study finds FDA-prohibited substances in sports supplements

August 19, 2023: Researchers have found anomalies in the accuracy of ingredient labels and the presence of FDA-prohibited substances in a variety of.

Read More
Drugs Health Pharma

France’s Ipsen clears FDA hurdle for bone disorder drug Sohonos

HQ Team August 17, 2023: Ipsen, a French drugmaker, has received FDA approval for its Sohonos capsules to treat a rare bone disorder.

Read More
Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients with metastatic uveal melanoma, giving the Delaware-based firm $60 million fund access.
Drugs Health Pharma

Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma

HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients.

Read More
The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that affects plasma cells made in the bone marrow, according to a company statement.
Drugs Health Pharma

US regulator approves Pfizer’s Elrexfio to treat multiple myeloma

HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that.

Read More
The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat multiple myeloma.
Drugs Health Pharma

USFDA green lights Janssen’s Talvey to treat multiple myeloma

HQ Team August 11, 2023: The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat.

Read More
Sweden’s Getinge Group is recalling its  cardiosave hybrid and rescue intra-aortic balloon pumps after the FDA initiated a most serious recall, Class 1.
Drugs Health Pharma

Getinge Group recalls intra-aortic pumps due to faulty power system

HQ Team August 11, 2023: Sweden’s Getinge Group is recalling its cardiosave hybrid and rescue intra-aortic balloon pumps after the FDA initiated a.

Read More
India’s Lupin Ltd. has the USFDA nod for making a generic birth control pill, according to a company statement.
Drugs Health Pharma

India’s Lupin gets FDA nod to make generic oral contraceptive

HQ Team August 2, 2023: India’s Lupin Ltd., the eighth largest generic pharmaceutical company in the world based on revenue, has received the.

Read More
Harm Reduction Therapeutics’s RiVive has become the second opioid overdose reversal drug the FDA allows without a prescription in the US.
Drugs Health Pharma

USFDA gives nod for second opioid overdose reversal drug ReVive

HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid.

Read More
Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio, according to a company statement
Drugs Health Pharma

Biogen Inc. to buy US-based Reata Pharmaceuticals for $7.3 billion

HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,.

Read More